Type II Secretory Phospholipase A2 and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study

Secretory Phospholipase ◽

Stable Coronary Heart Disease

Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease

European Heart Journal ◽

10.1093/eurheartj/ehp302 ◽

2009 ◽

Vol 30 (22) ◽

pp. 2742-2748 ◽

Cited By ~ 53

Author(s):

W. Koenig ◽

C. Y. Vossen ◽

Z. Mallat ◽

H. Brenner ◽

J. Benessiano ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Phospholipase A2 ◽

Cardiovascular Events ◽

Plasma Concentrations ◽

Type Ii ◽

The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease

Gene ◽

10.1016/j.gene.2015.03.030 ◽

2015 ◽

Vol 564 (1) ◽

pp. 29-34 ◽

Cited By ~ 5

Author(s):

Yulia A. Shuvalova ◽

Zukhra B. Khasanova ◽

Violetta I. Kaminnaya ◽

Elena V. Samoilova ◽

Alexandra A. Korotaeva ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Single Nucleotide Polymorphisms ◽

Phospholipase A2 ◽

Nucleotide Polymorphisms ◽

Single Nucleotide ◽

Secretory Phospholipase ◽

Stable Coronary Heart Disease

MS341 EFFECT OF NIACIN WITH ATORVASTATIN ON SECRETORY PHOSPHOLIPASE A2 IN MEN WITH CORONARY HEART DISEASE AND LIPOPROTEIN(a) EXCESS

Atherosclerosis Supplements ◽

10.1016/s1567-5688(10)70842-4 ◽

2010 ◽

Vol 11 (2) ◽

pp. 178 ◽

Cited By ~ 1

Author(s):

E. Trukhacheva ◽

M. Ezhov ◽

V. Titov ◽

O. Afanasieva ◽

M. Afanasieva ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Phospholipase A2 ◽

Lipoprotein A ◽

Novel Genetic Approach to Investigate the Role of Plasma Secretory Phospholipase A2 (sPLA 2 )-V Isoenzyme in Coronary Heart Disease

Circulation Cardiovascular Genetics ◽

10.1161/circgenetics.113.000271 ◽

2014 ◽

Vol 7 (2) ◽

pp. 144-150 ◽

Cited By ~ 19

Author(s):

Michael V. Holmes ◽

Holly J. Exeter ◽

Lasse Folkersen ◽

Christopher P. Nelson ◽

Montse Guardiola ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Phospholipase A2 ◽

Genetic Approach ◽

Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease

European Heart Journal ◽

10.1093/eurheartj/ehq374 ◽

2010 ◽

Vol 32 (8) ◽

pp. 999-1005 ◽

Cited By ~ 39

Author(s):

Robert S. Rosenson ◽

Michael Elliott ◽

Yuri Stasiv ◽

Colin Hislop ◽

M. Imburgia ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Phospholipase A2 ◽

Randomized Trial ◽

Secretory Phospholipase ◽

Lipoprotein Subclasses ◽

Atherogenic Lipoprotein

Inhibition by unsaturated fatty acids of type II secretory phospholipase A2 synthesis in guinea-pig alveolar macrophages

European Journal of Biochemistry ◽

10.1046/j.1432-1327.2000.01392.x ◽

2000 ◽

Vol 267 (12) ◽

pp. 3633-3639 ◽

Cited By ~ 9

Author(s):

Mounia Alaoui El Azher ◽

Nathalie Havet ◽

Monique Singer ◽

Claude Dumarey ◽

Lhousseine Touqui

Keyword(s):

Fatty Acids ◽

Guinea Pig ◽

Phospholipase A2 ◽

Alveolar Macrophages ◽

Unsaturated Fatty Acids ◽

Type Ii ◽

Limits of Mendelian Randomization Analyses in Selection of Secretory Phospholipase A2-IIA as a Valid Therapeutic Target for Prevention of Cardiovascular Disease

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2013.09.074 ◽

2014 ◽

Vol 63 (9) ◽

pp. 942-943 ◽

Cited By ~ 2

Author(s):

Robert S. Rosenson ◽

Eva Hurt-Camejo

Keyword(s):

Cardiovascular Disease ◽

Phospholipase A2 ◽

Therapeutic Target ◽

Mendelian Randomization ◽

Secretory Phospholipase ◽

Prevention Of Cardiovascular Disease ◽

Selection Of

The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ◽

10.1016/s0005-2760(97)00082-9 ◽

1997 ◽

Vol 1349 (1) ◽

pp. 43-54 ◽

Cited By ~ 77

Author(s):

Gen-ichi Atsumi ◽

Makoto Murakami ◽

Masae Tajima ◽

Satoko Shimbara ◽

Noriko Hara ◽

...

Keyword(s):

Arachidonic Acid ◽

Phospholipase A2 ◽

Type Ii ◽

Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?

Cardiovascular Research ◽

10.1016/s0008-6363(03)00324-9 ◽

2003 ◽

Vol 60 (1) ◽

pp. 68-77 ◽

Cited By ~ 39

Author(s):

H Niessen

Keyword(s):

Cardiovascular Disease ◽

Phospholipase A2 ◽

Ischemic Damage ◽

Type Ii ◽

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2007.11.079 ◽

2008 ◽

Vol 51 (17) ◽

pp. 1632-1641 ◽

Cited By ~ 150

Author(s):

Emile R. Mohler ◽

Christie M. Ballantyne ◽

Michael H. Davidson ◽

Markolf Hanefeld ◽

Luis M. Ruilope ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Phospholipase A2 ◽

Coronary Heart Disease Risk ◽

Disease Risk ◽

Stable Coronary Heart Disease ◽

Heart Disease Risk ◽

Phospholipase A2 Activity ◽

Risk Equivalent ◽

Cardiovascular Biomarkers